Prognostic factor analysis in mycosis fungoides/Sézary syndrome.
about
Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementMycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphomaGenetic markers associated with progression in early mycosis fungoides.Transient CD30+ nodal transformation of cutaneous T-cell lymphoma associated with cyclosporine treatment.Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.Development of a plaque infiltrated with large CD30+ T cells over a silicone-containing device in a patient with history of Sézary syndromeCD30 expression and proliferative fraction in nontransformed mycosis fungoidesCutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors.Long-term outcomes of 1,263 patients with mycosis fungoides and Sézary syndrome from 1982 to 2009.Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.The biomarker landscape in mycosis fungoides and Sézary syndrome.Is PUVA maintenance therapy necessary in patients with early-stage mycosis fungoides? Evaluation of a treatment guideline over a 28-month follow-up.Sézary cell counts in erythrodermic cutaneous T-cell lymphoma: implications for prognosis and staging.A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma.Prognostic factors and risk stratification in early mycosis fungoides.Are we close to a prognostic index for cutaneous T cell lymphoma?Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management.Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis.Prognostic indicators for mycosis fungoides in a Greek population.
P2860
Q27024076-BC5A2147-28CC-4DCD-B93B-48CCE731F83FQ30252152-1539A9F4-71D5-48FF-9A75-8E65EDFAA4BBQ33386623-4A6B6A6F-D174-45B1-8F3F-5B806984D2B2Q33556038-69933629-0D0B-4970-8EBF-B4AC0B4EC179Q34434751-C60CDD69-C95A-4244-92CD-7968EB48AF40Q35584244-E9DCE138-9AEE-4DC6-8278-676F5F7CE766Q36470196-A649F6BC-790F-41AF-B902-711748808156Q36865775-1CAB1655-4377-47BA-A831-C72F59CA2717Q37070128-44CC009B-66BF-4D6C-B0A1-F50A93A2801AQ37163606-0700AAB5-F9A6-4E22-9106-E58D12DC45A0Q37296614-E0B5BA55-A2CB-43CB-89D7-4169C955BF53Q37379370-43F5EB6D-D594-4F24-A082-FB97FCDE7638Q37944565-5097FB95-B0A8-4ED0-B3AC-B51867C4B55CQ38196931-55A09068-1363-4D94-9393-5AE2F817CAB7Q38765889-2E3B8FFD-BFC2-4996-A557-E393AE62EB14Q39023382-7497B8FC-EA97-4FD8-882B-D6632A1E6864Q39775429-7B1A9C76-C3E3-4F5F-A2DF-7D820F7443A6Q40275753-677FC298-AD8C-467E-AAAD-192E278FEB5FQ43612578-FC080D2D-83D1-4F86-864C-EEBAD998E7C5Q43680684-C64585F7-5923-4ACB-8F2E-21B679003F49Q44382232-BA978E91-375A-4730-A5E6-FB15ED182D53Q47654977-6B9213BB-9CC3-4828-BEB8-1E1A6E36B3E6Q48034709-4E325156-68F3-4172-B9C5-8243EB455B7AQ50630512-ACF62180-4EB9-4B94-8719-B2F8AB20F3C8Q53039521-50321465-894B-4F2D-AE31-A709BBF4E8AD
P2860
Prognostic factor analysis in mycosis fungoides/Sézary syndrome.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Prognostic factor analysis in mycosis fungoides/Sézary syndrome.
@ast
Prognostic factor analysis in mycosis fungoides/Sézary syndrome.
@en
type
label
Prognostic factor analysis in mycosis fungoides/Sézary syndrome.
@ast
Prognostic factor analysis in mycosis fungoides/Sézary syndrome.
@en
prefLabel
Prognostic factor analysis in mycosis fungoides/Sézary syndrome.
@ast
Prognostic factor analysis in mycosis fungoides/Sézary syndrome.
@en
P2093
P1476
Prognostic factor analysis in mycosis fungoides/Sézary syndrome.
@en
P2093
P304
P356
10.1016/S0190-9622(99)70079-4
P407
P433
P577
1999-06-01T00:00:00Z